For autoimmune applications, cycling also provides opportunities to assess disease activity off peptide and determine whether improvements are sustained
Biotransformation of a parent drug results in metabolites that may be active or inactive themselves
One preclinical study finding BPC-157 inhibited melanoma provides limited reassurance, but comprehensive human oncological safety data would require extensive trials that no one has conducted
This peptide is supplied exclusively for research purposes and is not approved as a medicine, supplement, or therapeutic product in Thailand or elsewhere
Another interesting outcome was that GSH treatment did not change the efficiency of MRAB resistance to the antibiotics (Augmentin, ciprofloxacin, gentamicin and tobramycin) tested in this study (Supplementary Figures S1AD), indicating that GSH does not influence MRABs gene expression profile, however, further research is needed to ascertain the validity of these findings